rs28715870

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_004006.3(DMD):ā€‹c.4162T>Gā€‹(p.Phe1388Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00498 in 1,208,952 control chromosomes in the GnomAD database, including 158 homozygotes. There are 1,659 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā˜…ā˜…). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.

Frequency

Genomes: š‘“ 0.026 ( 89 hom., 777 hem., cov: 22)
Exomes š‘“: 0.0029 ( 69 hom. 882 hem. )

Consequence

DMD
NM_004006.3 missense

Scores

15

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:15

Conservation

PhyloP100: 1.47
Variant links:
Genes affected
DMD (HGNC:2928): (dystrophin) This gene spans a genomic range of greater than 2 Mb and encodes a large protein containing an N-terminal actin-binding domain and multiple spectrin repeats. The encoded protein forms a component of the dystrophin-glycoprotein complex (DGC), which bridges the inner cytoskeleton and the extracellular matrix. Deletions, duplications, and point mutations at this gene locus may cause Duchenne muscular dystrophy (DMD), Becker muscular dystrophy (BMD), or cardiomyopathy. Alternative promoter usage and alternative splicing result in numerous distinct transcript variants and protein isoforms for this gene. [provided by RefSeq, Dec 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0022250712).
BP6
Variant X-32411823-A-C is Benign according to our data. Variant chrX-32411823-A-C is described in ClinVar as [Benign]. Clinvar id is 94615.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-32411823-A-C is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0837 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
DMDNM_004006.3 linkuse as main transcriptc.4162T>G p.Phe1388Val missense_variant 30/79 ENST00000357033.9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
DMDENST00000357033.9 linkuse as main transcriptc.4162T>G p.Phe1388Val missense_variant 30/791 NM_004006.3 P4

Frequencies

GnomAD3 genomes
AF:
0.0256
AC:
2846
AN:
111321
Hom.:
89
Cov.:
22
AF XY:
0.0227
AC XY:
762
AN XY:
33519
show subpopulations
Gnomad AFR
AF:
0.0860
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0142
Gnomad ASJ
AF:
0.00189
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00339
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00418
Gnomad NFE
AF:
0.000452
Gnomad OTH
AF:
0.0200
GnomAD3 exomes
AF:
0.00767
AC:
1403
AN:
182914
Hom.:
33
AF XY:
0.00539
AC XY:
364
AN XY:
67584
show subpopulations
Gnomad AFR exome
AF:
0.0892
Gnomad AMR exome
AF:
0.00577
Gnomad ASJ exome
AF:
0.00120
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00105
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000319
Gnomad OTH exome
AF:
0.00376
GnomAD4 exome
AF:
0.00287
AC:
3153
AN:
1097580
Hom.:
69
Cov.:
31
AF XY:
0.00243
AC XY:
882
AN XY:
363016
show subpopulations
Gnomad4 AFR exome
AF:
0.0855
Gnomad4 AMR exome
AF:
0.00662
Gnomad4 ASJ exome
AF:
0.00150
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00122
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000270
Gnomad4 OTH exome
AF:
0.00697
GnomAD4 genome
AF:
0.0257
AC:
2864
AN:
111372
Hom.:
89
Cov.:
22
AF XY:
0.0231
AC XY:
777
AN XY:
33580
show subpopulations
Gnomad4 AFR
AF:
0.0865
Gnomad4 AMR
AF:
0.0142
Gnomad4 ASJ
AF:
0.00189
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00302
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000452
Gnomad4 OTH
AF:
0.0198
Alfa
AF:
0.00447
Hom.:
190
Bravo
AF:
0.0292
ESP6500AA
AF:
0.0900
AC:
345
ESP6500EA
AF:
0.000595
AC:
4
ExAC
AF:
0.00872
AC:
1059
EpiCase
AF:
0.000327
EpiControl
AF:
0.000652

ClinVar

Significance: Benign
Submissions summary: Benign:15
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:8
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Jan 25, 2016- -
Benign, criteria provided, single submitterclinical testingGeneDxJan 09, 2014This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineJan 13, 2015p.Phe1388Val in exon 30 of DMD: This variant is not expected to have clinical si gnificance because it has been identified in 9% (345/3833) of African American c hromosomes by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/E VS/; dbSNP rs28715870). -
Benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpMar 30, 2020Variant summary: DMD c.4162T>G (p.Phe1388Val) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.0077 in 182914 control chromosomes in the gnomAD database, including 33 homozygotes and 364 hemizygotes. The observed variant frequency is approximately 695 fold of the estimated maximal expected allele frequency for a pathogenic variant in DMD causing Dystrophinopathies phenotype (1.1e-05), strongly suggesting that the variant is benign. Seven clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as benign/likely benign. Based on the evidence outlined above, the variant was classified as benign. -
Benign, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsJan 12, 2021- -
Benign, no assertion criteria providedclinical testingLaboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)-- -
not provided Benign:3
Benign, criteria provided, single submitterclinical testingCenter for Pediatric Genomic Medicine, Children's Mercy Hospital and ClinicsJun 04, 2015- -
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesApr 24, 2023- -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Duchenne muscular dystrophy;C0878544:Cardiomyopathy;C0917713:Becker muscular dystrophy;na:Dystrophin deficiency Benign:1
Benign, no assertion criteria providedclinical testingNatera, Inc.Apr 21, 2017- -
Dilated cardiomyopathy 3B Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Duchenne muscular dystrophy Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Cardiovascular phenotype Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsFeb 15, 2016This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.048
BayesDel_addAF
Benign
-0.92
T
BayesDel_noAF
Benign
-1.0
CADD
Benign
13
DANN
Benign
0.91
DEOGEN2
Benign
0.22
.;T;.;.
FATHMM_MKL
Benign
0.087
N
LIST_S2
Benign
0.61
T;.;T;T
MetaRNN
Benign
0.0022
T;T;T;T
MetaSVM
Benign
-1.0
T
MutationTaster
Benign
1.0
P;P
PrimateAI
Benign
0.32
T
PROVEAN
Benign
0.020
.;N;.;N
REVEL
Benign
0.024
Sift
Benign
0.26
.;T;.;T
Sift4G
Benign
0.28
T;T;T;T
Polyphen
0.0
.;B;.;.
Vest4
0.055
MVP
0.15
MPC
0.016
ClinPred
0.0017
T
GERP RS
3.1
gMVP
0.081

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs28715870; hg19: chrX-32429940; API